Search Results

Filter
  • 1-10 of  512 results for ""Receptor, IGF Type 1""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Teprotumumab for the Treatment of Thyroid Eye Disease.

  • Authors : Ugradar S; Department of Orbit and Thyroid Eye Disease Thrive Health, Beverly Hills, CA, USA.; Malkhasyan E

Subjects: Graves Ophthalmopathy*/Graves Ophthalmopathy*/Graves Ophthalmopathy*/drug therapy ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/pharmacology

  • Source: Endocrine reviews [Endocr Rev] 2024 Nov 22; Vol. 45 (6), pp. 843-857.Publisher: Oxford University Press Country of Publication: United States NLM ID: 8006258 Publication Model: Print Cited

Record details

×
Academic Journal

PAPP-A as a Potential Target in Thyroid Eye Disease.

  • Authors : Conover CA; Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.; Bale LK

Subjects: Graves Ophthalmopathy*/Graves Ophthalmopathy*/Graves Ophthalmopathy*/metabolism ; Graves Ophthalmopathy*/Graves Ophthalmopathy*/Graves Ophthalmopathy*/pathology ; Graves Ophthalmopathy*/Graves Ophthalmopathy*/Graves Ophthalmopathy*/drug therapy

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Nov 18; Vol. 109 (12), pp. 3119-3125.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited

Record details

×
Academic Journal

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

  • Authors : de Billy E; Department of Onco-hematology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.; Pellegrino M

Subjects: Brain Stem Neoplasms*/Brain Stem Neoplasms*/Brain Stem Neoplasms*/pathology ; Glioma*/Glioma*/Glioma*/drug therapy ; Glioma*/Glioma*/Glioma*/genetics

  • Source: Neuro-oncology [Neuro Oncol] 2022 Jul 01; Vol. 24 (7), pp. 1150-1163.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Differential expression of insulin-like growth factor type 1 receptor identifies heterogeneous intrahepatic regulatory T subsets in mouse hepatocellular carcinoma.

  • Authors : Huang Y; Department of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, PR China.; Huang L

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/metabolism ; Receptor, IGF Type 1*/Receptor, IGF Type 1*/Receptor, IGF Type 1*/genetics

  • Source: Clinical and experimental immunology [Clin Exp Immunol] 2022 May 13; Vol. 208 (1), pp. 47-59.Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Sequential activation of uterine epithelial IGF1R by stromal IGF1 and embryonic IGF2 directs normal uterine preparation for embryo implantation.

  • Authors : Zhou C; State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing, China.; Fujian Provincial Key Laboratory of Reproductive Health Research, School of Medicine, Xiamen University, Xiamen, China.

Subjects: Embryo Implantation*; Insulin-Like Growth Factor I/Insulin-Like Growth Factor I/Insulin-Like Growth Factor I/*metabolism ; Insulin-Like Growth Factor II/Insulin-Like Growth Factor II/Insulin-Like Growth Factor II/*metabolism

  • Source: Journal of molecular cell biology [J Mol Cell Biol] 2021 Dec 06; Vol. 13 (9), pp. 646-661.Publisher: Oxford University Press Country of Publication: United States NLM ID: 101503669 Publication Model: Print Cited

Record details

×
Academic Journal

GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation.

  • Authors : Fesler Z; Department of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada.; Mitova E

Subjects: Epidermal Growth Factor/Epidermal Growth Factor/Epidermal Growth Factor/*pharmacology ; Glucagon-Like Peptide 2/Glucagon-Like Peptide 2/Glucagon-Like Peptide 2/*metabolism ; Intestinal Mucosa/Intestinal Mucosa/Intestinal Mucosa/*metabolism

  • Source: Endocrinology [Endocrinology] 2020 Apr 01; Vol. 161 (4).Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print Cited

Record details

×
Academic Journal

Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

  • Authors : Smith TJ; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, and Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.; Janssen JAMJL

Subjects: Graves Ophthalmopathy*/Graves Ophthalmopathy*/Graves Ophthalmopathy*/drug therapy ; Graves Ophthalmopathy*/Graves Ophthalmopathy*/Graves Ophthalmopathy*/immunology ; Graves Ophthalmopathy*/Graves Ophthalmopathy*/Graves Ophthalmopathy*/metabolism

  • Source: Endocrine reviews [Endocr Rev] 2019 Feb 01; Vol. 40 (1), pp. 236-267.Publisher: Oxford University Press Country of Publication: United States NLM ID: 8006258 Publication Model: Print Cited

Record details

×
Academic Journal

Arrestin-β-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk.

  • Authors : Krieger CC; Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.; Boutin A

Subjects: Receptor, IGF Type 1/Receptor, IGF Type 1/Receptor, IGF Type 1/*metabolism ; Receptors, Thyrotropin/Receptors, Thyrotropin/Receptors, Thyrotropin/*metabolism ; Thyroid Epithelial Cells/Thyroid Epithelial Cells/Thyroid Epithelial Cells/*metabolism

  • Source: Endocrinology [Endocrinology] 2019 Jun 01; Vol. 160 (6), pp. 1468-1479.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print Cited

Record details

×
Academic Journal

Selenium deficiency induces splenic growth retardation by deactivating the IGF-1R/PI3K/Akt/mTOR pathway.

  • Authors : Wang J; College of Animal Science and Veterinary Medicine in Heilongjiang Bayi Agricultural University, Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, P. R. China. .; Lian S

Subjects: Phosphoinositide-3 Kinase Inhibitors*; Growth Disorders/Growth Disorders/Growth Disorders/*etiology ; Proto-Oncogene Proteins c-akt/Proto-Oncogene Proteins c-akt/Proto-Oncogene Proteins c-akt/*antagonists & inhibitors

  • Source: Metallomics : integrated biometal science [Metallomics] 2018 Nov 14; Vol. 10 (11), pp. 1570-1575.Publisher: Oxford University Press Country of Publication: England NLM ID: 101478346 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Characterization of an activating R1353H insulin-like growth factor 1 receptor variant in a male with extreme tall height.

  • Authors : Lin Y; Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska (CCK), Karolinska University Hospital, Stockholm, Sweden.; van Duyvenvoorde HA

Subjects: Down-Regulation* ; Point Mutation*; Growth Disorders/Growth Disorders/Growth Disorders/*genetics

  • Source: European journal of endocrinology [Eur J Endocrinol] 2018 Aug; Vol. 179 (2), pp. 85-95. Date of Electronic Publication: 2018 May 22.Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print-Electronic Cited

Record details

×
  • 1-10 of  512 results for ""Receptor, IGF Type 1""